Harvard
Stroomberg, HV, Vojdeman, FJ, Madsen, CM, Helgstrand, JT, Schwarz, P, Heegaard, A-M, Olsen, A, Tjønneland, A
, Struer Lind, B, Brasso, K, Jørgensen, HL & Røder, MA 2020, '
Vitamin D levels and the risk of prostate cancer and prostate cancer mortality'
Acta Oncologica.
https://doi.org/10.1080/0284186X.2020.1837391
APA
Stroomberg, H. V., Vojdeman, F. J., Madsen, C. M., Helgstrand, J. T., Schwarz, P., Heegaard, A-M.
, ... Røder, M. A. (2020).
Vitamin D levels and the risk of prostate cancer and prostate cancer mortality.
Acta Oncologica.
https://doi.org/10.1080/0284186X.2020.1837391
CBE
Stroomberg HV, Vojdeman FJ, Madsen CM, Helgstrand JT, Schwarz P, Heegaard A-M, Olsen A, Tjønneland A
, Struer Lind B, Brasso K, Jørgensen HL, Røder MA. 2020.
Vitamin D levels and the risk of prostate cancer and prostate cancer mortality.
Acta Oncologica.
https://doi.org/10.1080/0284186X.2020.1837391
MLA
Vancouver
Author
Stroomberg, Hein Vincent ; Vojdeman, Fie Juhl ; Madsen, Christian Medom ; Helgstrand, John Thomas ; Schwarz, Peter ; Heegaard, Anne-Marie ; Olsen, Anja ; Tjønneland, Anne
; Struer Lind, Bent ; Brasso, Klaus ; Jørgensen, Henrik Løvendahl ; Røder, Martin Andreas. /
Vitamin D levels and the risk of prostate cancer and prostate cancer mortality. I:
Acta Oncologica. 2020.
Bibtex
@article{15e5b95ce34446f8b221ab7fad835f3c,
title = "Vitamin D levels and the risk of prostate cancer and prostate cancer mortality",
abstract = "BACKGROUND: Vitamin D has a role in bone turnover and potentially bone-metastatic spread of prostate cancer (PCa). The aim of this observational study was to address the association between levels of serum vitamin D, diagnosis of PCa and subsequent mortality in men who underwent a biopsy of the prostate.METHODS: All men who underwent prostatic biopsy in the Danish PCa Registry (DaPCaR) and who had a serum vitamin D measurement during the period 2004 to 2010 (n = 4,065) were identified. Men were categorized by clinical cut-offs based on seasonally adjusted serum vitamin D levels in <25 (deficient), 25-50 (insufficient), 50-75 (sufficient) and >75 nmol/L (high) serum vitamin D. Logistic regression model for association between vitamin D and risk of PCa diagnosis and multivariate survival analyses were applied.RESULTS: No association between serum vitamin D and risk of PCa was found. Overall survival was lowest for serum vitamin D deficiency and a significantly higher PCa specific mortality (HR: 2.37, 95{\%}CI: 1.45-3.90, p < .001) and other cause mortality (HR: 2.08, 95{\%}CI: 1.33-3.24, p = .001) was found for PCa patients with serum vitamin D deficiency compared to serum vitamin D sufficiency.CONCLUSION: No association was found between serum vitamin D categories and risk of PCa in men who underwent biopsy of the prostate. Men with PCa and serum vitamin D deficiency had a higher overall and PCa specific mortality compared to men with a sufficient level of serum vitamin D.",
keywords = "epidemiology, mortality, Prostatic neoplasms, risk, Vitamin D",
author = "Stroomberg, {Hein Vincent} and Vojdeman, {Fie Juhl} and Madsen, {Christian Medom} and Helgstrand, {John Thomas} and Peter Schwarz and Anne-Marie Heegaard and Anja Olsen and Anne Tj{\o}nneland and {Struer Lind}, Bent and Klaus Brasso and J{\o}rgensen, {Henrik L{\o}vendahl} and R{\o}der, {Martin Andreas}",
year = "2020",
month = "10",
day = "24",
doi = "10.1080/0284186X.2020.1837391",
language = "English",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Informa Healthcare",
}
RIS
TY - JOUR
T1 - Vitamin D levels and the risk of prostate cancer and prostate cancer mortality
AU - Stroomberg, Hein Vincent
AU - Vojdeman, Fie Juhl
AU - Madsen, Christian Medom
AU - Helgstrand, John Thomas
AU - Schwarz, Peter
AU - Heegaard, Anne-Marie
AU - Olsen, Anja
AU - Tjønneland, Anne
AU - Struer Lind, Bent
AU - Brasso, Klaus
AU - Jørgensen, Henrik Løvendahl
AU - Røder, Martin Andreas
PY - 2020/10/24
Y1 - 2020/10/24
N2 - BACKGROUND: Vitamin D has a role in bone turnover and potentially bone-metastatic spread of prostate cancer (PCa). The aim of this observational study was to address the association between levels of serum vitamin D, diagnosis of PCa and subsequent mortality in men who underwent a biopsy of the prostate.METHODS: All men who underwent prostatic biopsy in the Danish PCa Registry (DaPCaR) and who had a serum vitamin D measurement during the period 2004 to 2010 (n = 4,065) were identified. Men were categorized by clinical cut-offs based on seasonally adjusted serum vitamin D levels in <25 (deficient), 25-50 (insufficient), 50-75 (sufficient) and >75 nmol/L (high) serum vitamin D. Logistic regression model for association between vitamin D and risk of PCa diagnosis and multivariate survival analyses were applied.RESULTS: No association between serum vitamin D and risk of PCa was found. Overall survival was lowest for serum vitamin D deficiency and a significantly higher PCa specific mortality (HR: 2.37, 95%CI: 1.45-3.90, p < .001) and other cause mortality (HR: 2.08, 95%CI: 1.33-3.24, p = .001) was found for PCa patients with serum vitamin D deficiency compared to serum vitamin D sufficiency.CONCLUSION: No association was found between serum vitamin D categories and risk of PCa in men who underwent biopsy of the prostate. Men with PCa and serum vitamin D deficiency had a higher overall and PCa specific mortality compared to men with a sufficient level of serum vitamin D.
AB - BACKGROUND: Vitamin D has a role in bone turnover and potentially bone-metastatic spread of prostate cancer (PCa). The aim of this observational study was to address the association between levels of serum vitamin D, diagnosis of PCa and subsequent mortality in men who underwent a biopsy of the prostate.METHODS: All men who underwent prostatic biopsy in the Danish PCa Registry (DaPCaR) and who had a serum vitamin D measurement during the period 2004 to 2010 (n = 4,065) were identified. Men were categorized by clinical cut-offs based on seasonally adjusted serum vitamin D levels in <25 (deficient), 25-50 (insufficient), 50-75 (sufficient) and >75 nmol/L (high) serum vitamin D. Logistic regression model for association between vitamin D and risk of PCa diagnosis and multivariate survival analyses were applied.RESULTS: No association between serum vitamin D and risk of PCa was found. Overall survival was lowest for serum vitamin D deficiency and a significantly higher PCa specific mortality (HR: 2.37, 95%CI: 1.45-3.90, p < .001) and other cause mortality (HR: 2.08, 95%CI: 1.33-3.24, p = .001) was found for PCa patients with serum vitamin D deficiency compared to serum vitamin D sufficiency.CONCLUSION: No association was found between serum vitamin D categories and risk of PCa in men who underwent biopsy of the prostate. Men with PCa and serum vitamin D deficiency had a higher overall and PCa specific mortality compared to men with a sufficient level of serum vitamin D.
KW - epidemiology
KW - mortality
KW - Prostatic neoplasms
KW - risk
KW - Vitamin D
U2 - 10.1080/0284186X.2020.1837391
DO - 10.1080/0284186X.2020.1837391
M3 - Journal article
JO - Acta Oncologica
JF - Acta Oncologica
SN - 0284-186X
ER -